相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients
Jose A. Mira et al.
AIDS (2012)
Meta-analysis: the impact of IL28B polymorphisms on rapid and sustained virological response in HCV-2 and -3 patients
J. Schreiber et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin
L. Valenti et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-a and ribavirin
Y. Chen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Predicting sustained viral response to hepatitis C using a rapid and simple IL28B rs8099917 genotyping assay
Wei Li et al.
ANTIVIRAL RESEARCH (2012)
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C
Salvatore Petta et al.
ANTIVIRAL THERAPY (2012)
IL28B and interferon-gamma inducible protein 10 for prediction of rapid virologic response and sustained virologic response in HIV-HCV-coinfected patients
Berit A. Payer et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
IL28B favorable genotype and ultrarapid viral response as the earliest treatment predictors of a sustained viral response in a Georgian cohort infected with the hepatitis C genotype 1
Marine Karchava et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Interleukin-28B polymorphisms on the SVR in the treatment of naive chronic hepatitis C with pegylated interferon-α plus ribavirin: A meta-analysis
Ke-Qing Shi et al.
GENE (2012)
Frequency of IL28B rs12979860 Single-Nucleotide Polymorphism Alleles in Newborn Infants and in Patients with Chronic Hepatitis C in Morocco
Mariam Tajir et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2012)
IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection
Vito Di Marco et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
The Correlation of Il28B Genotype With Sustained Virologic Response In Romanian patients With Chronic Hepatitis C
Ioan Sporea et al.
Hepatitis Monthly (2012)
Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection
Janett Fischer et al.
HEPATOLOGY (2012)
Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy
Christian M. Lange et al.
HEPATOLOGY (2012)
Factors responsible for the discrepancy between IL28B polymorphism prediction and the viral response to peginterferon plus ribavirin therapy in Japanese chronic hepatitis C patients
Hiroaki Saito et al.
HEPATOLOGY RESEARCH (2012)
Amino Acid Substitution in HCV Core Region and Genetic Variation near the IL28B Gene Affect Viral Dynamics during Telaprevir, Peginterferon and Ribavirin Treatment
Norio Akuta et al.
INTERVIROLOGY (2012)
Pharmacogenetics of hepatitis C
Vincent Soriano et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus
Mariko Kobayashi et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Prediction of response to pegylated interferon/ribavirin combination therapy for chronic hepatitis C genotype 1b and high viral load
Soo Ryang Kim et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Randomized trial of peginterferon α-2a plus ribavirin versus peginterferon α-2b plus ribavirin for chronic hepatitis C in Japanese patients
Shiho Miyase et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Predicting response to therapy in chronic hepatitis C: An approach combining interleukin-28B gene polymorphisms and clinical data
Jose M. Ladero et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1
Eiichi Ogawa et al.
JOURNAL OF HEPATOLOGY (2012)
Single nucleotide polymorphism upstream of interleukin 28B associated with phase 1 and phase 2 of early viral kinetics in patients infected with HCV genotype 1
Charles D. Howell et al.
JOURNAL OF HEPATOLOGY (2012)
A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping
Jose Ramon Vidal-Castineira et al.
JOURNAL OF HEPATOLOGY (2012)
IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C
Tarik Asselah et al.
JOURNAL OF HEPATOLOGY (2012)
Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin
Chung-Feng Huang et al.
JOURNAL OF HEPATOLOGY (2012)
Early anemia and rapid virological response improve the predictive efficiency of IL28B-genotype for treatment outcome to antiviral combination therapy in patients infected with chronic HCV genotype 1
Ahmad Amanzada et al.
JOURNAL OF MEDICAL VIROLOGY (2012)
The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin
Zobair M. Younossi et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Lymphotropic hepatitis C virus has an interferon-resistant phenotype
M. Inokuchi et al.
JOURNAL OF VIRAL HEPATITIS (2012)
IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection
H. -Y. Rao et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Negative HCV-RNA 2 weeks after initiation of treatment predicts sustained virological response to pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis C
Peer Brehm Christensen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Prediction of response to pegylated-interferon-α and ribavirin therapy in Chinese patients infected with different hepatitis C virus genotype
Xiaoyan Guo et al.
VIROLOGY JOURNAL (2012)
IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin
Norma I. Rallon et al.
AIDS (2011)
IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C
G. Fattovich et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
IL28B Genomic-Based Treatment Paradigms for Patients With Chronic Hepatitis C Infection: The Future of Personalized HCV Therapies
Paul J. Clark et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
The IL-28B Genotype Predicts Which Slow-Responding Hepatitis C-Infected Patients Will Benefit from Treatment Extension
Brian L. Pearlman et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Importance of Host Genetic Factors HLA and IL28B as Predictors of Response to Pegylated Interferon and Ribavirin
Paloma Munoz de Rueda et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Association of genetic variation in IL28B with hepatitis C treatment-induced viral clearance in the Chinese Han population
Xiang-Wei Liao et al.
ANTIVIRAL THERAPY (2011)
IL28B CC-genotype association with HLA-DQB1*0301 allele increases the prediction of spontaneous HCV RNA clearance in thalassaemic HCV-infected patients
Alessandra Mangia et al.
ANTIVIRAL THERAPY (2011)
Marked impact of IL28B genotype in the natural clearance of hepatitis C virus in patients with haemoglobinopathies
Maria Concetta Renda et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-Naive Patients With Chronic Hepatitis C
Albert Friedrich Staettermayer et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Redefining Baseline Demographics: The Role of Genetic Testing in Hepatitis C Virus Infection
Jacinta A. Holmes et al.
CLINICS IN LIVER DISEASE (2011)
Association of Interleukin-28B and Hepatitis C Genotype 1 with a High Viral Load and Response to Pegylated Interferon plus Ribavirin Therapy
Masahiro Takita et al.
DIGESTION (2011)
A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus
Philippe Halfon et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2011)
High-Dose Pegylated Interferon-α and Ribavirin in Nonresponder Hepatitis C Patients and Relationship With IL-28B Genotype (SYREN Trial)
Stephane Chevaliez et al.
GASTROENTEROLOGY (2011)
A Polymorphism in IL28B Distinguishes Exposed, Uninfected Individuals From Spontaneous Resolvers of HCV Infection
Susanne Knapp et al.
GASTROENTEROLOGY (2011)
Interferon-Induced Gene Expression Is a Stronger Predictor of Treatment Response Than IL28B Genotype in Patients With Hepatitis C
Michael T. Dill et al.
GASTROENTEROLOGY (2011)
IL28B genetic variations are associated with high sustained virological response (SVR) of interferon-α plus ribavirin therapy in Taiwanese chronic HCV infection
J-Y Chen et al.
GENES AND IMMUNITY (2011)
Limited Use of Interleukin 28B in the Setting of Response-Guided Treatment with Detailed On-Treatment Virological Monitoring
Alessandra Mangia et al.
HEPATOLOGY (2011)
IL28B Genetic Variation and Treatment Response in Patients with Hepatitis C Virus Genotype 3 Infection
Amir Moghaddam et al.
HEPATOLOGY (2011)
Hepatitis C Pharmacogenetics: State of the Art in 2010
Nezam H. Afdhal et al.
HEPATOLOGY (2011)
High Predictive Accuracy of an Unbiased Proteomic Profile for Sustained Virologic Response in Chronic Hepatitis C Patients
Keyur Patel et al.
HEPATOLOGY (2011)
Quantitation of Pretreatment Serum Interferon-gamma-Inducible Protein-10 Improves the Predictive Value of an IL28B Gene Polymorphism for Hepatitis C Treatment Response
Jama M. Darling et al.
HEPATOLOGY (2011)
Role of Interleukin-28B Polymorphisms in the Treatment of Hepatitis C Virus Genotype 2 Infection in Asian Patients
Ming-Lung Yu et al.
HEPATOLOGY (2011)
Suppressor of cytokine signal 3 and IL28 genetic variation predict the viral response to peginterferon and ribavirin
Hisamitsu Miyaaki et al.
HEPATOLOGY RESEARCH (2011)
Hepatitis C Virus Infection and Coinfection With Human Immunodeficiency Virus Challenges and Advancements in Management
Colleen Hadigan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Polymorphism near the IL28B gene in Korean hepatitis C virus-infected patients treated with peg-interferon plus ribavirin
KwangSoo Lyoo et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
IL-28B predicts response to chronic hepatitis C therapy - fine-mapping and replication study in Asian populations
Hidenori Ochi et al.
JOURNAL OF GENERAL VIROLOGY (2011)
The predictive value of IL28B gene polymorphism for spontaneous clearance in a single source outbreak cohort is limited in patients carrying the CCR5Δ32 mutation
Jacob Nattermann et al.
JOURNAL OF HEPATOLOGY (2011)
Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors
Masayuki Kurosaki et al.
JOURNAL OF HEPATOLOGY (2011)
Genetic Variation in IL28B and Treatment-induced Clearance of Hepatitis C Virus in HIV-Positive Patients With Acute and Chronic Hepatitis C
Jacob Nattermann et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Interleukin 28B Gene Variation at rs12979860 Determines Early Viral Kinetics During Treatment in Patients Carrying Genotypes 2 or 3 of Hepatitis C Virus
Magnus Lindh et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C
Kazuaki Chayama et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Association of IL28B Variants With Response to Pegylated-Interferon Alpha Plus Ribavirin Combination Therapy Reveals Intersubgenotypic Differences Between Genotypes 2a and 2b
Naoya Sakamoto et al.
JOURNAL OF MEDICAL VIROLOGY (2011)
IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1
M. Lindh et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy
Kazuhiko Hayashi et al.
LIVER INTERNATIONAL (2011)
Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment
Manuel Romero-Gomez et al.
LIVER INTERNATIONAL (2011)
Boceprevir for Chronic HCV Genotype 1 Infection
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
Kenneth E. Sherman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Dysregulation of IFN System Can Lead to Poor Response to Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis C
Koji Onomoto et al.
PLOS ONE (2011)
An IL28B Genotype-Based Clinical Prediction Model for Treatment of Chronic Hepatitis C
Thomas R. O'Brien et al.
PLOS ONE (2011)
Hepatic STAT1-Nuclear Translocation and Interleukin 28B Polymorphisms Predict Treatment Outcomes in Hepatitis C Virus Genotype 1-Infected Patients
Tatsuo Miyamura et al.
PLOS ONE (2011)
Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy
Ching-Sheng Hsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection
Megan M. Dring et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients
Mauricio Venegas et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort
Katherine R. Smith et al.
GENOME MEDICINE (2011)
IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study
Vijayaprakash Suppiah et al.
PLOS MEDICINE (2011)
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Modeling the Probability of Sustained Virological Response to Therapy with Pegylated Interferon plus Ribavirin in Patients Coinfected with Hepatitis C Virus and HIV
Jose Medrano et al.
CLINICAL INFECTIOUS DISEASES (2010)
Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus
Alexander J. Thompson et al.
GASTROENTEROLOGY (2010)
Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection
Jason Grebely et al.
HEPATOLOGY (2010)
Amino Acid Substitution in Hepatitis C Virus Core Region and Genetic Variation Near the Interleukin 28B Gene Predict Viral Response to Telaprevir with Peginterferon and Ribavirin
Norio Akuta et al.
HEPATOLOGY (2010)
Interleukin-28B Genetic Variants and Hepatitis Virus Infection by Different Viral Genotypes
Marco Antonio Montes-Cano et al.
HEPATOLOGY (2010)
IL28B SNP rs8099917 Is Strongly Associated with Pegylated Interferon-α and Ribavirin Therapy Treatment Failure in HCV/HIV-1 Coinfected Patients
Ester Aparicio et al.
PLOS ONE (2010)
Diagnosis, Management, and Treatment of Hepatitis C: An Update
Marc G. Ghany et al.
HEPATOLOGY (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
David L. Thomas et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Distributions of Hardy-Weinberg Equilibrium Test Statistics
R. V. Rohlfs et al.
GENETICS (2008)
Random-effects model for meta-analysis of clinical trials: An update
Rebecca DerSimonian et al.
CONTEMPORARY CLINICAL TRIALS (2007)
Interferons α and λ inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics
Tobias Marcello et al.
GASTROENTEROLOGY (2006)
A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints
Roger M. Harbord et al.
STATISTICS IN MEDICINE (2006)
Genetic variation, classification and 'race'
LB Jorde et al.
NATURE GENETICS (2004)
An illustrated guide to the methods of meta-analysis
AJ Sutton et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2001)
分享论文
